Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Frommer

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Die Naturwissenschaften|October 1, 1977
alpha-Glucosidase inhibitors. New complex oligosaccharides of microbial originD D Schmidt, W Frommer, B Junge, et al.
International Journal of Molecular Sciences|August 25, 2019
The Adipokine Network in Rheumatic Joint DiseasesMar Carrión, Klaus W Frommer, Selene Pérez-García, et al.
Journal of Molecular Endocrinology|August 12, 2006
IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578TKlaus W Frommer, Katharina Reichenmiller, Burkhardt S Schutt, et al.
Experimental and Molecular Pathology|November 1, 2011
Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritisKristina Eisinger, Sabrina Bauer, Andreas Schäffler, et al.
Joint Bone Spine|June 17, 2015
Differentiation of osteophyte types in osteoarthritis - proposal of a histological classificationSusann Junker, Grit Krumbholz, Klaus W Frommer, et al.
Applied Microbiology and Biotechnology|November 1, 1992
Safe biotechnology (4). Recommendations for safety levels for biotechnological operations with microorganisms that cause diseases in plantsW Frommer, L Archer, B Boon, et al.
Applied Microbiology and Biotechnology|May 1, 1993
Safe biotechnology (5). Recommendations for safe work with animal and human cell cultures concerning potential human pathogensW Frommer, L Archer, B Boon, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis?Klaus W Frommer, Andreas Schäffler, Christa Büchler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 25, 2014
Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progressionUta Syrbe, Johanna Callhoff, Kristina Conrad, et al.
Clinical and Experimental Rheumatology|January 13, 2017
Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectinGrit Krumbholz, Susann Junker, Florian M P Meier, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Die Naturwissenschaften|October 1, 1977
alpha-Glucosidase inhibitors. New complex oligosaccharides of microbial originD D Schmidt, W Frommer, B Junge, et al.
International Journal of Molecular Sciences|August 25, 2019
The Adipokine Network in Rheumatic Joint DiseasesMar Carrión, Klaus W Frommer, Selene Pérez-García, et al.
Journal of Molecular Endocrinology|August 12, 2006
IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578TKlaus W Frommer, Katharina Reichenmiller, Burkhardt S Schutt, et al.
Experimental and Molecular Pathology|November 1, 2011
Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritisKristina Eisinger, Sabrina Bauer, Andreas Schäffler, et al.
Joint Bone Spine|June 17, 2015
Differentiation of osteophyte types in osteoarthritis - proposal of a histological classificationSusann Junker, Grit Krumbholz, Klaus W Frommer, et al.
Applied Microbiology and Biotechnology|November 1, 1992
Safe biotechnology (4). Recommendations for safety levels for biotechnological operations with microorganisms that cause diseases in plantsW Frommer, L Archer, B Boon, et al.
Applied Microbiology and Biotechnology|May 1, 1993
Safe biotechnology (5). Recommendations for safe work with animal and human cell cultures concerning potential human pathogensW Frommer, L Archer, B Boon, et al.
Annals of the Rheumatic Diseases|April 26, 2012
Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis?Klaus W Frommer, Andreas Schäffler, Christa Büchler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 25, 2014
Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progressionUta Syrbe, Johanna Callhoff, Kristina Conrad, et al.
Clinical and Experimental Rheumatology|January 13, 2017
Response of human rheumatoid arthritis osteoblasts and osteoclasts to adiponectinGrit Krumbholz, Susann Junker, Florian M P Meier, et al.
Pageof 5